Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 736 entries
Sorted by: Best Match Show Resources per page
Evaluation of the performance enhancement of silicone biofouling-release coatings by oil incorporation.

Biofouling

Truby K, Wood C, Stein J, Cella J, Carpenter J, Kavanagh C, Swain G, Wiebe D, Lapota D, Meyer A, Holm E, Wendt D, Smith C, Montemarano J.
PMID: 22115299
Biofouling. 2000;15(1):141-50. doi: 10.1080/08927010009386305.

In response to increased evidence of ecosystem damage by toxic antifouling paints, many researchers have developed nontoxic silicone fouling release coatings. The fouling release capability of these Systems may be improved by adding nonbonding silicone oils to the coating...

Cite
Truby K, Wood C, Stein J, et al. Evaluation of the performance enhancement of silicone biofouling-release coatings by oil incorporation. Biofouling. 2000;15(1):141-50doi: 10.1080/08927010009386305.
Truby, K., Wood, C., Stein, J., Cella, J., Carpenter, J., Kavanagh, C., Swain, G., Wiebe, D., Lapota, D., Meyer, A., Holm, E., Wendt, D., Smith, C., & Montemarano, J. (2000). Evaluation of the performance enhancement of silicone biofouling-release coatings by oil incorporation. Biofouling, 15(1), 141-50. https://doi.org/10.1080/08927010009386305
Truby, K, et al. "Evaluation of the performance enhancement of silicone biofouling-release coatings by oil incorporation." Biofouling vol. 15,1 (2000): 141-50. doi: https://doi.org/10.1080/08927010009386305
Truby K, Wood C, Stein J, Cella J, Carpenter J, Kavanagh C, Swain G, Wiebe D, Lapota D, Meyer A, Holm E, Wendt D, Smith C, Montemarano J. Evaluation of the performance enhancement of silicone biofouling-release coatings by oil incorporation. Biofouling. 2000;15(1):141-50. doi: 10.1080/08927010009386305. PMID: 22115299.
Copy Download .nbib Format: NLM
Long-term effect of a single dose of flunarizine in Huntington's disease.

European journal of neurology

Belfiore G, Campanella G, Cella S, De Michele G, Di Maio L, Filla A, Napolitano G.
PMID: 10210839
Eur J Neurol. 1998 May;5(3):249-253. doi: 10.1046/j.1468-1331.1998.530249.x.

We report a preliminary pilot study on the clinical efficacy of flunarizine (FNZ), a calcium-entry blocker that causes extrapyramidal side-effects, in 10 patients with Huntington's disease (HD). FNZ (20 mg) administered by the sublingual route resulted in a decrease...

Cite
Belfiore G, Campanella G, Cella S, et al. Long-term effect of a single dose of flunarizine in Huntington's disease. Eur J Neurol. 1998;5(3):249-253doi: 10.1046/j.1468-1331.1998.530249.x.
Belfiore, G., Campanella, G., Cella, S., De Michele G, Di Maio L, Filla, A., & Napolitano, G. (1998). Long-term effect of a single dose of flunarizine in Huntington's disease. European journal of neurology, 5(3), 249-253. https://doi.org/10.1046/j.1468-1331.1998.530249.x
Belfiore, et al. "Long-term effect of a single dose of flunarizine in Huntington's disease." European journal of neurology vol. 5,3 (1998): 249-253. doi: https://doi.org/10.1046/j.1468-1331.1998.530249.x
Belfiore G, Campanella G, Cella S, De Michele G, Di Maio L, Filla A, Napolitano G. Long-term effect of a single dose of flunarizine in Huntington's disease. Eur J Neurol. 1998 May;5(3):249-253. doi: 10.1046/j.1468-1331.1998.530249.x. PMID: 10210839.
Copy Download .nbib Format: NLM
Swendsen-Wang update algorithm for the Symanzik improved sigma model.

Physical review. D, Particles and fields

Buonanno A, Cella G.
PMID: 10018343
Phys Rev D Part Fields. 1995 May 15;51(10):5865-5869. doi: 10.1103/physrevd.51.5865.

No abstract available.

Cite
Buonanno A, Cella G. Swendsen-Wang update algorithm for the Symanzik improved sigma model. Phys Rev D Part Fields. 1995;51(10):5865-5869doi: 10.1103/physrevd.51.5865.
Buonanno, A., & Cella, G. (1995). Swendsen-Wang update algorithm for the Symanzik improved sigma model. Physical review. D, Particles and fields, 51(10), 5865-5869. https://doi.org/10.1103/physrevd.51.5865
Buonanno, and Cella. "Swendsen-Wang update algorithm for the Symanzik improved sigma model." Physical review. D, Particles and fields vol. 51,10 (1995): 5865-5869. doi: https://doi.org/10.1103/physrevd.51.5865
Buonanno A, Cella G. Swendsen-Wang update algorithm for the Symanzik improved sigma model. Phys Rev D Part Fields. 1995 May 15;51(10):5865-5869. doi: 10.1103/physrevd.51.5865. PMID: 10018343.
Copy Download .nbib Format: NLM
Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings.

Journal of patient-reported outcomes

Galipeau N, Klooster B, Krohe M, Tang DH, Revicki DA, Cella D.
PMID: 30734110
J Patient Rep Outcomes. 2019 Feb 07;3(1):10. doi: 10.1186/s41687-019-0098-1.

BACKGROUND: Patients with breast cancer experience a variety of disease symptoms and treatment-related side effects that can adversely affect functioning. The breast cancer experience may differ across disease stages and biomarker subtypes. This study identified relevant disease symptoms, treatment-related...

Cite
Galipeau N, Klooster B, Krohe M, et al. Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings. J Patient Rep Outcomes. 2019;3(1):10doi: 10.1186/s41687-019-0098-1.
Galipeau, N., Klooster, B., Krohe, M., Tang, D. H., Revicki, D. A., & Cella, D. (2019). Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings. Journal of patient-reported outcomes, 3(1), 10. https://doi.org/10.1186/s41687-019-0098-1
Galipeau, Nina, et al. "Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings." Journal of patient-reported outcomes vol. 3,1 (2019): 10. doi: https://doi.org/10.1186/s41687-019-0098-1
Galipeau N, Klooster B, Krohe M, Tang DH, Revicki DA, Cella D. Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings. J Patient Rep Outcomes. 2019 Feb 07;3(1):10. doi: 10.1186/s41687-019-0098-1. PMID: 30734110; PMCID: PMC6367496.
Copy Download .nbib Format: NLM
Blueprint for Advancing High-Value Maternity Care Through Physiologic Childbearing.

The Journal of perinatal education

Avery MD, Bell AD, Bingham D, Corry MP, Delbanco SF, Gullo SL, Ivory CH, Jennings JC, Kennedy HP, Kozhimannil KB, Leeman L, Lothian JA, Miller HD, Ogburn T, Romano A, Sakala C, Shah NT.
PMID: 30364339
J Perinat Educ. 2018 Jun;27(3):130-134. doi: 10.1891/1058-1243.27.3.130.

The

Cite
Avery MD, Bell AD, Bingham D, et al. Blueprint for Advancing High-Value Maternity Care Through Physiologic Childbearing. J Perinat Educ. 2018;27(3):130-134doi: 10.1891/1058-1243.27.3.130.
Avery, M. D., Bell, A. D., Bingham, D., Corry, M. P., Delbanco, S. F., Gullo, S. L., Ivory, C. H., Jennings, J. C., Kennedy, H. P., Kozhimannil, K. B., Leeman, L., Lothian, J. A., Miller, H. D., Ogburn, T., Romano, A., Sakala, C., & Shah, N. T. (2018). Blueprint for Advancing High-Value Maternity Care Through Physiologic Childbearing. The Journal of perinatal education, 27(3), 130-134. https://doi.org/10.1891/1058-1243.27.3.130
Avery, Melissa D, et al. "Blueprint for Advancing High-Value Maternity Care Through Physiologic Childbearing." The Journal of perinatal education vol. 27,3 (2018): 130-134. doi: https://doi.org/10.1891/1058-1243.27.3.130
Avery MD, Bell AD, Bingham D, Corry MP, Delbanco SF, Gullo SL, Ivory CH, Jennings JC, Kennedy HP, Kozhimannil KB, Leeman L, Lothian JA, Miller HD, Ogburn T, Romano A, Sakala C, Shah NT. Blueprint for Advancing High-Value Maternity Care Through Physiologic Childbearing. J Perinat Educ. 2018 Jun;27(3):130-134. doi: 10.1891/1058-1243.27.3.130. PMID: 30364339; PMCID: PMC6193356.
Copy Download .nbib Format: NLM
Visceral leishmaniasis triggering an adult-onset Still's disease: a unique case.

Clinical case reports

Spoto S, Costantino S, Valeriani E, Fogolari M, Cella E, Dicuonzo G, Ciccozzi M, Angeletti S.
PMID: 29225867
Clin Case Rep. 2017 Nov 13;5(12):2111-2116. doi: 10.1002/ccr3.1266. eCollection 2017 Dec.

Adult-onset Still's disease (AOSD) due to visceral leishmaniasis (VL) has not been previously reported. This case report analyzes a single episode of AOSD probably due to a visceral leishmaniasis successfully treated with pentamidine isethionate and prednisone.

Cite
Spoto S, Costantino S, Valeriani E, et al. Visceral leishmaniasis triggering an adult-onset Still's disease: a unique case. Clin Case Rep. 2017;5(12):2111-2116doi: 10.1002/ccr3.1266.
Spoto, S., Costantino, S., Valeriani, E., Fogolari, M., Cella, E., Dicuonzo, G., Ciccozzi, M., & Angeletti, S. (2017). Visceral leishmaniasis triggering an adult-onset Still's disease: a unique case. Clinical case reports, 5(12), 2111-2116. https://doi.org/10.1002/ccr3.1266
Spoto, Silvia, et al. "Visceral leishmaniasis triggering an adult-onset Still's disease: a unique case." Clinical case reports vol. 5,12 (2017): 2111-2116. doi: https://doi.org/10.1002/ccr3.1266
Spoto S, Costantino S, Valeriani E, Fogolari M, Cella E, Dicuonzo G, Ciccozzi M, Angeletti S. Visceral leishmaniasis triggering an adult-onset Still's disease: a unique case. Clin Case Rep. 2017 Nov 13;5(12):2111-2116. doi: 10.1002/ccr3.1266. eCollection 2017 Dec. PMID: 29225867; PMCID: PMC5715570.
Copy Download .nbib Format: NLM
Erratum to: Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy.

BMC infectious diseases

Villano U, Lo Presti A, Equestre M, Cella E, Pisani G, Giovanetti M, Bruni R, Tritarelli E, Amicosante M, Grifoni A, Scarcella C, El-Hamad I, Pezzoli MC, Angeletti S, Ciccaglione AR, Ciccozzi M.
PMID: 26578229
BMC Infect Dis. 2015 Nov 17;15:531. doi: 10.1186/s12879-015-1245-9.

No abstract available.

Cite
Villano U, Lo Presti A, Equestre M, et al. Erratum to: Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy. BMC Infect Dis. 2015;15:531doi: 10.1186/s12879-015-1245-9.
Villano, U., Lo Presti, A., Equestre, M., Cella, E., Pisani, G., Giovanetti, M., Bruni, R., Tritarelli, E., Amicosante, M., Grifoni, A., Scarcella, C., El-Hamad, I., Pezzoli, M. C., Angeletti, S., Ciccaglione, A. R., & Ciccozzi, M. (2015). Erratum to: Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy. BMC infectious diseases, 15531. https://doi.org/10.1186/s12879-015-1245-9
Villano, Umbertina, et al. "Erratum to: Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy." BMC infectious diseases vol. 15 (2015): 531. doi: https://doi.org/10.1186/s12879-015-1245-9
Villano U, Lo Presti A, Equestre M, Cella E, Pisani G, Giovanetti M, Bruni R, Tritarelli E, Amicosante M, Grifoni A, Scarcella C, El-Hamad I, Pezzoli MC, Angeletti S, Ciccaglione AR, Ciccozzi M. Erratum to: Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy. BMC Infect Dis. 2015 Nov 17;15:531. doi: 10.1186/s12879-015-1245-9. PMID: 26578229; PMCID: PMC4650508.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in public health

Adebamowo SN, Ma B, Zella D, Famooto A, Ravel J, Adebamowo C.
PMID: 28695118
Front Public Health. 2017 Jun 26;5:140. doi: 10.3389/fpubh.2017.00140. eCollection 2017.

BACKGROUND: Recent studies have suggested that the vaginal microenvironment plays a role in persistence of high-risk human papillomavirus (hrHPV) infection and thus cervical carcinogenesis. Furthermore, it has been shown that some mycoplasmas are efficient methylators and may facilitate carcinogenesis...

Cite
Adebamowo SN, Ma B, Zella D, et al. . Front Public Health. 2017;5:140doi: 10.3389/fpubh.2017.00140.
Adebamowo, S. N., Ma, B., Zella, D., Famooto, A., Ravel, J., Adebamowo, C. (2017). . Frontiers in public health, 5140. https://doi.org/10.3389/fpubh.2017.00140
Adebamowo, Sally N, et al. "." Frontiers in public health vol. 5 (2017): 140. doi: https://doi.org/10.3389/fpubh.2017.00140
Adebamowo SN, Ma B, Zella D, Famooto A, Ravel J, Adebamowo C. . Front Public Health. 2017 Jun 26;5:140. doi: 10.3389/fpubh.2017.00140. eCollection 2017. PMID: 28695118; PMCID: PMC5483445.
Copy Download .nbib Format: NLM
From protein-protein interactions to protein co-expression networks: a new perspective to evaluate large-scale proteomic data.

EURASIP journal on bioinformatics & systems biology

Vella D, Zoppis I, Mauri G, Mauri P, Di Silvestre D.
PMID: 28477207
EURASIP J Bioinform Syst Biol. 2017 Dec;2017(1):6. doi: 10.1186/s13637-017-0059-z. Epub 2017 Mar 20.

The reductionist approach of dissecting biological systems into their constituents has been successful in the first stage of the molecular biology to elucidate the chemical basis of several biological processes. This knowledge helped biologists to understand the complexity of...

Cite
Vella D, Zoppis I, Mauri G, et al. From protein-protein interactions to protein co-expression networks: a new perspective to evaluate large-scale proteomic data. EURASIP J Bioinform Syst Biol. 2017;2017(1):6doi: 10.1186/s13637-017-0059-z.
Vella, D., Zoppis, I., Mauri, G., Mauri, P., & Di Silvestre, D. (2017). From protein-protein interactions to protein co-expression networks: a new perspective to evaluate large-scale proteomic data. EURASIP journal on bioinformatics & systems biology, 2017(1), 6. https://doi.org/10.1186/s13637-017-0059-z
Vella, Danila, et al. "From protein-protein interactions to protein co-expression networks: a new perspective to evaluate large-scale proteomic data." EURASIP journal on bioinformatics & systems biology vol. 2017,1 (2017): 6. doi: https://doi.org/10.1186/s13637-017-0059-z
Vella D, Zoppis I, Mauri G, Mauri P, Di Silvestre D. From protein-protein interactions to protein co-expression networks: a new perspective to evaluate large-scale proteomic data. EURASIP J Bioinform Syst Biol. 2017 Dec;2017(1):6. doi: 10.1186/s13637-017-0059-z. Epub 2017 Mar 20. PMID: 28477207; PMCID: PMC5359264.
Copy Download .nbib Format: NLM
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Archives of medical science : AMS

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M.
PMID: 28883839
Arch Med Sci. 2017 Aug;13(5):965-1005. doi: 10.5114/aoms.2017.69326. Epub 2017 Aug 04.

No abstract available.

Cite
Cicero AFG, Colletti A, Bajraktari G, et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci. 2017;13(5):965-1005doi: 10.5114/aoms.2017.69326.
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., Panagiotakos, D. B., Paragh, G., Mikhailidis, D. P., Mitchenko, O., Paulweber, B., Pella, D., Pitsavos, C., Reiner, �. �., Ray, K. K., Rizzo, M., Sahebkar, A., Serban, M. C., Sperling, L. S., Toth, P. P., Vinereanu, D., Vrablík, M., Wong, N. D., & Banach, M. (2017). Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Archives of medical science : AMS, 13(5), 965-1005. https://doi.org/10.5114/aoms.2017.69326
Cicero, Arrigo F G, et al. "Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel." Archives of medical science : AMS vol. 13,5 (2017): 965-1005. doi: https://doi.org/10.5114/aoms.2017.69326
Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci. 2017 Aug;13(5):965-1005. doi: 10.5114/aoms.2017.69326. Epub 2017 Aug 04. PMID: 28883839; PMCID: PMC5575230.
Copy Download .nbib Format: NLM
Static bistability of spherical caps.

Proceedings. Mathematical, physical, and engineering sciences

Taffetani M, Jiang X, Holmes DP, Vella D.
PMID: 29887751
Proc Math Phys Eng Sci. 2018 May;474(2213):20170910. doi: 10.1098/rspa.2017.0910. Epub 2018 May 16.

Depending on its geometry, a spherical shell may exist in one of two stable states without the application of any external force: there are two 'self-equilibrated' states, one natural and the other inside out (or 'everted'). Though this is...

Cite
Taffetani M, Jiang X, Holmes DP, et al. Static bistability of spherical caps. Proc Math Phys Eng Sci. 2018;474(2213):20170910doi: 10.1098/rspa.2017.0910.
Taffetani, M., Jiang, X., Holmes, D. P., & Vella, D. (2018). Static bistability of spherical caps. Proceedings. Mathematical, physical, and engineering sciences, 474(2213), 20170910. https://doi.org/10.1098/rspa.2017.0910
Taffetani, Matteo, et al. "Static bistability of spherical caps." Proceedings. Mathematical, physical, and engineering sciences vol. 474,2213 (2018): 20170910. doi: https://doi.org/10.1098/rspa.2017.0910
Taffetani M, Jiang X, Holmes DP, Vella D. Static bistability of spherical caps. Proc Math Phys Eng Sci. 2018 May;474(2213):20170910. doi: 10.1098/rspa.2017.0910. Epub 2018 May 16. PMID: 29887751; PMCID: PMC5990688.
Copy Download .nbib Format: NLM
Quality of Life in Patients With Primary and Metastatic Brain Tumors in the Literature as Assessed by the FACT-Br.

World journal of oncology

Chiu N, Chiu L, Zeng L, Zhang L, Cella D, Popovic M, Chow R, Lam H, Poon M, Chow E.
PMID: 29147319
World J Oncol. 2012 Dec;3(6):280-285. doi: 10.4021/wjon585w. Epub 2013 Jan 04.

BACKGROUND: The Functional Assessment of Cancer Therapy-Brain (FACT-Br) is a quality of life (QOL) assessment tool that was originally developed for use in patients with primary brain tumors. However, the tool has also been used to assess QOL in...

Cite
Chiu N, Chiu L, Zeng L, et al. Quality of Life in Patients With Primary and Metastatic Brain Tumors in the Literature as Assessed by the FACT-Br. World J Oncol. 2013;3(6):280-285doi: 10.4021/wjon585w.
Chiu, N., Chiu, L., Zeng, L., Zhang, L., Cella, D., Popovic, M., Chow, R., Lam, H., Poon, M., & Chow, E. (2012). Quality of Life in Patients With Primary and Metastatic Brain Tumors in the Literature as Assessed by the FACT-Br. World journal of oncology, 3(6), 280-285. https://doi.org/10.4021/wjon585w
Chiu, Nicholas, et al. "Quality of Life in Patients With Primary and Metastatic Brain Tumors in the Literature as Assessed by the FACT-Br." World journal of oncology vol. 3,6 (2012): 280-285. doi: https://doi.org/10.4021/wjon585w
Chiu N, Chiu L, Zeng L, Zhang L, Cella D, Popovic M, Chow R, Lam H, Poon M, Chow E. Quality of Life in Patients With Primary and Metastatic Brain Tumors in the Literature as Assessed by the FACT-Br. World J Oncol. 2012 Dec;3(6):280-285. doi: 10.4021/wjon585w. Epub 2013 Jan 04. PMID: 29147319; PMCID: PMC5649806.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 736 entries